Search News
| 10.82 Delayed Data As of Jul 20 |  -0.26 / -2.35%Today’s Change | 2.52 Today|||52-Week Range 14.45 | +77.09% Year-to-Date |
| Previous close | 11.08 |
| Today’s open | 11.11 |
| Day’s range | 10.80 - 11.37 |
| Volume | 308,122 |
| Average volume (3 months) | 596,252 |
| Market cap | $571.9M |
| Earnings growth (last year) | +2.86% |
| Earnings growth (this year) | -5.07% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -6.72% |
| P/E ratio | NM |
| Price/Sales | 62.47 |
| Price/Book | 7.38 |
| Today’s change | Today’s % change | |
|---|---|---|
| VBIVVBI Vaccines Inc | -0.11 | -3.89% |
| CGENCompugen Ltd | -0.13 | -3.57% |
| VBLTVascular Biogenics L... | 0.00 | 0.00% |
| KMDAKamada Ltd | 0.00 | 0.00% |
| Next reporting date | August 7, 2018 |
| EPS forecast (this quarter) | -$0.26 |
| Annual revenue (last year) | $4.1M |
| Annual profit (last year) | -$43.0M |
| Net profit margin | -1,046.08% |
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director J. Scott Wolchko |
Chief Scientific Officer Daniel D. Shoemaker |
Corporate headquarters San Diego, California |
